Suven Gets Product Patents for Neurodegenerative Disorders
Suven Life Sciences has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity (NCE) for the treatment of disorders associated with neurodegenerative diseases. These patents are valid till 2034, the company said in a stock exchange filing.
“We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally,” Suven’s CEO, Mr. Venkat Jasti said. The granted claims of the patents are being developed as therapeutic agents useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson’s and schizophrenia, the filing added.
You May Interested In
2026-09-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Sulfur Price Hits 7,633 CNY/Ton, Up Nearly Sixfold in a Year and a Half; Domestic Refining Giants Halt New Orders Due to Tight Supply
-
When the Skin of Ships Gets More Expensive: A 30% Price Shock Is Quietly Rewriting the Cost Floor of Global Shipping
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
U.S. Chemical Tariff Deadline Nears as the Industry Faces Cost Repricing and Supply-Chain Adjustment
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Trump’s Steel, Aluminum and Copper Tariff Changes Pull Chemical Manufacturing Into the Impact Zone
-
EU Plans Broader Quotas and Tariffs on China, With Chemicals Clearly Named
-
Is India’s “Luck” Finally Here? HPCL’s 10-Year LNG Deal Is a High-Stakes Bet on National Destiny
Recommend Reading
-
![After 20 Years of Negotiations, 90% of Tariffs to Be Cut! EU and Mercosur Sign Free Trade Agreement: Trade Barriers Ease, Transatlantic Cooperation Warms Up?]()
After 20 Years of Negotiations, 90% of Tariffs to Be Cut! EU and Mercosur Sign Free Trade Agreement: Trade Barriers Ease, Transatlantic Cooperation Warms Up?
-
![Sherwin-Williams Opens High-Performance Industrial Coatings Facility in Saskatchewan]()
Sherwin-Williams Opens High-Performance Industrial Coatings Facility in Saskatchewan
-
![Kemira Acquires AquaBlue]()
Kemira Acquires AquaBlue
-
![Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure]()
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
![API Supplier Audits Move to the Center of Pharma Supply Resilience]()
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
![Premium Global Chemical Sourcing Requests (28-31May, 2026)]()
Premium Global Chemical Sourcing Requests (28-31May, 2026)
-
![Applications of Caesium Iodide]()
Applications of Caesium Iodide
-
![Negative Factors Weigh Down, Hydrogen Peroxide Market Weakens]()
Negative Factors Weigh Down, Hydrogen Peroxide Market Weakens
-
![China's Acetone Market Reverses Decline and Rises]()
China's Acetone Market Reverses Decline and Rises
-
![Weak Balance Under Cost Support—Melamine Market Struggles to Stay Firm]()
Weak Balance Under Cost Support—Melamine Market Struggles to Stay Firm
